Health Economics Overview

Principles

Definition

Health economics is a specialized field that applies economic theory and methods to the study of health, healthcare, and related markets. It investigates how scarce resources are allocated and utilized within the health sector, examining the production, consumption, and distribution of health services, the determinants of health outcomes, and the functioning of healthcare systems. Key characteristics include the analysis of efficiency, equity, incentives, and market structures unique to healthcare, with its significance lying in providing a framework for understanding complex issues in health policy, evaluating interventions, and informing decisions related to resource allocation.

Ontological type

Core Theories

Policy Applications

Methodological Tools

Key developments

Key Figures

Foundational Methodology era

Milton C. Weinstein [1] was a leading figure in health economics during the Foundational Methodology era, with affiliations at Harvard University [3] and Karolinska Institutet [4]. His key contributions in this era include establishing foundational cost-effectiveness analysis for health and medical practices [5], and evaluating interventions to prevent or treat coronary heart disease to illustrate how economic evaluation guides resource allocation [6], which helped anchor economic reasoning in health policy and enable comparability across interventions. Peter Tugwell [2] was active in health economics during this era with affiliations at Harvard University [3] and Karolinska Institutet [4]. His contribution includes proposing tentative guidelines for when a new technology warrants adoption and utilization based on clinical and economic evaluations, as reflected in his paper How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations [7], which helped standardize how economic evidence informs technology adoption decisions.

Standardization and Integration era

Donald M. Berwick [1] is associated with Harvard University [3] and Johns Hopkins University [4] during the Standardization and Integration era (1996–2009). His key contribution in this era is The Triple Aim: Care, Health, And Cost [7], which advanced standardized, integrated approaches to measuring value and informing policy and resource allocation. Paul Dolan [2] is associated with Princeton University [5] and Imperial College London [6] during this era. His key contribution in this era is Modeling Valuations for EuroQol Health States [8], which provided methods to quantify health-state preferences and support the standardized use of QALYs in economic evaluations.

Global Value-Based Evaluation era

Andrew Briggs [1], anchored academically at Harvard University [3] and Stanford University [4], emerged as a pivotal figure in health economics during the Global Value-Based Evaluation era. His key contributions center on consolidating CHEERS - Explanation and Elaboration [7], the CHEERS statement [8], and CHEERS 2022 Explanation and Elaboration [9], milestones that standardized reporting practices and enabled cross-country comparability and reproducibility of economic evaluations in this era. Stavros Petrou [2], associated with University of Cambridge [5] and Erasmus University Rotterdam [6], is a prominent leader in health economics during this era. Petrou's contributions to CHEERS - Explanation and Elaboration 2013 [7], CHEERS statement 2013 [8], and CHEERS 2022 Explanation and Elaboration [9] helped standardize economic evaluation reporting, promoting transparency and cross-national comparability essential for value-based decision making.